Developing a non-invasive ultrasound neuromodulation platform designed to engage the body’s anti-inflammatory neural pathways for treatment of chronic inflammatory disorders.
Surf Therapeutics is developing ultrasound-based neuromodulation aimed at anti-inflammatory neural pathways, making it more adjacent to bioelectronic medicine than central neurotechnology. Its ultrasound approach is distinctive, though still early.